Nath Bio-Genes (India) Limited — Updates, 30-07-2026: General Updates
30-07-2026 | 12:57 pm
30-07-2026 | 12:57 pm
Nath Bio-Genes delivered strong Q1FY27 results: Revenue grew 15% to ₹322.8 Cr, EBITDA rose 17% to ₹35.1 Cr, and PAT increased 12% to ₹32.7 Cr. Operational highlights include Maize volume up 44% (value 59%) and Paddy volume up 19% (value 34%).
No comments yet. Be the first to comment!
